147 related articles for article (PubMed ID: 33773040)
1. F5-Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV-short production.
Zimowski KL; Petrillo T; Ho MD; Wechsler J; Shields JE; Denning G; Jhita N; Rivera AA; Escobar MA; Kempton CL; Camire RM; Doering CB
J Thromb Haemost; 2021 Jul; 19(7):1653-1665. PubMed ID: 33773040
[TBL] [Abstract][Full Text] [Related]
2. Factor V east Texas variant causes bleeding in a three-generation family.
Peterson JA; Gupta S; Martinez ND; Hardesty B; Maroney SA; Mast AE
J Thromb Haemost; 2022 Mar; 20(3):565-573. PubMed ID: 34847292
[TBL] [Abstract][Full Text] [Related]
3. Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.
Vincent LM; Tran S; Livaja R; Bensend TA; Milewicz DM; Dahlbäck B
J Clin Invest; 2013 Sep; 123(9):3777-87. PubMed ID: 23979162
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency.
Nuzzo F; Bulato C; Nielsen BI; Lee K; Wielders SJ; Simioni P; Key NS; Castoldi E
Haemophilia; 2015 Mar; 21(2):241-248. PubMed ID: 25470420
[TBL] [Abstract][Full Text] [Related]
5. Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder.
Broze GJ; Girard TJ
J Clin Invest; 2013 Sep; 123(9):3710-2. PubMed ID: 23979154
[TBL] [Abstract][Full Text] [Related]
6. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
Dahlbäck B
Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
Dahlbäck B
J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.
Dall'Osso C; Guella I; Duga S; Locatelli N; Paraboschi EM; Spreafico M; Afrasiabi A; Pechlaner C; Peyvandi F; Tenchini ML; Asselta R
Haematologica; 2008 Oct; 93(10):1505-13. PubMed ID: 18728029
[TBL] [Abstract][Full Text] [Related]
9. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma.
Castoldi E; Duckers C; Radu C; Spiezia L; Rossetto V; Tagariello G; Rosing J; Simioni P
J Thromb Haemost; 2011 May; 9(5):959-68. PubMed ID: 21320286
[TBL] [Abstract][Full Text] [Related]
10. Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα.
van Doorn P; Rosing J; Campello E; Middeldorp S; Simioni P; Meijers JCM; Hackeng TM; Castoldi E
Thromb Haemost; 2020 Jan; 120(1):55-64. PubMed ID: 31705518
[TBL] [Abstract][Full Text] [Related]
11. Gene Dosage of
Gemmati D; D'Aversa E; Antonica B; Grisafi M; Salvatori F; Pizzicotti S; Pellegatti P; Ciccone M; Moratelli S; Serino ML; Tisato V
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674367
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of a novel missense mutation identified in a Turkish patient affected by severe coagulation factor V deficiency.
Paraboschi EM; Kayiran SM; Özbek N; Gürakan B; Peyvandi F; Guella I; Duga S; Asselta R
Haemophilia; 2012 Mar; 18(2):205-10. PubMed ID: 21777354
[TBL] [Abstract][Full Text] [Related]
13. Natural anticoagulant discovery, the gift that keeps on giving: finding FV-Short.
Dahlbäck B
J Thromb Haemost; 2023 Apr; 21(4):716-727. PubMed ID: 36746318
[TBL] [Abstract][Full Text] [Related]
14. Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study.
Tinholt M; Garred Ø; Borgen E; Beraki E; Schlichting E; Kristensen V; Sahlberg KK; Iversen N
J Thromb Haemost; 2018 Jul; 16(7):1347-1356. PubMed ID: 29766637
[TBL] [Abstract][Full Text] [Related]
15. Identification of three F5 gene mutations associated with inherited coagulation factor V deficiency in two Chinese pedigrees.
Fu QH; Zhou RF; Liu LG; Wang WB; Wu WM; Ding QL; Hu YQ; Wang XF; Wang ZY; Wang HL
Haemophilia; 2004 May; 10(3):264-70. PubMed ID: 15086325
[TBL] [Abstract][Full Text] [Related]
16. Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.
Petrillo T; Ayombil F; Van't Veer C; Camire RM
J Biol Chem; 2021; 296():100234. PubMed ID: 33376137
[TBL] [Abstract][Full Text] [Related]
17. [Phenotypic and genetic analysis of a pedigree affected with hereditary FV deficiency due to a novel deletional variant of F5 gene].
Ding H; Su K; Hu L; Zhang H; Zhu L; Yang L; Jin Y; Wang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Nov; 36(11):1100-1103. PubMed ID: 31703135
[TBL] [Abstract][Full Text] [Related]
18. Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.
Ellery PE; Maroney SA; Martinez ND; Wickens MP; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):187-95. PubMed ID: 24233486
[TBL] [Abstract][Full Text] [Related]
19. Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation.
Nuzzo F; Radu C; Baralle M; Spiezia L; Hackeng TM; Simioni P; Castoldi E
Blood; 2013 Nov; 122(23):3825-31. PubMed ID: 24085767
[TBL] [Abstract][Full Text] [Related]
20. Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain.
Asselta R; Montefusco MC; Duga S; Malcovati M; Peyvandi F; Mannucci PM; Tenchini ML
J Thromb Haemost; 2003 Jun; 1(6):1237-44. PubMed ID: 12871325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
